GREY:ICOTF - Post by User
Post by
PivotPointNewsWireon Nov 15, 2012 1:44pm
737 Views
Post# 20605640
$2-4 dollar valuation on positive Phase 2 007 Resu
$2-4 dollar valuation on positive Phase 2 007 Resu A new report is available on https://www.pivotpointnewswire.com/ showcasing a $2-4 dollar valuation for
iCo Therapeutics (ICO.V) based on postive phase II data from 007 clinical studies.